机构:[1]The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, 510220, China广东省中医院[2]The Cardiovascular Hospital of Shanxi, Taiyuan, 030000, China[3]Research Center of Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China[4]Department of Laboratory Medicine, Panyu Hospital of Chines Medicine, Guangzhou University of Chinese Medicine, 511400, China深圳市中医院深圳医学信息中心[5]Department of Laboratory Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Key Laboratory of Research on Emergency in TCM, Guangzhou, 510120, China大德路总院检验科大德路总院检验科广东省中医院
The pathogenesis of atherosclerosis is closely related to endothelial cell injury caused by lipid peroxidation-induced ferroptosis. Tanshinone IIA (TSA) protects endothelial tissues from damage. In this study, we investigated whether TSA exerts its protective effect on endothelial cells by inhibiting ferroptosis. Ferroptosis was induced in human coronary artery endothelial cells (HCAECs), and cells were treated with TSA. Morphological examination indicated that TSA exerted a significant protective effect on the HCAECs. This was further confirmed by LDH release and cell death detection assays. Flow cytometry revealed that TSA significantly reduced the excessive accumulation of total cellular ROS and lipid ROS caused by ferroptosis inducers. TSA also restored the reduction of glutathione (GSH), a potent and abundant reductant in cells. In addition, we found that TSA promoted the expression of NRF2, an essential player in response to oxidative stress, and its downstream genes. Immunofluorescent staining revealed that TSA promoted the nuclear translocation of NRF2. Increased nuclear translocation of NRF2 was validated by Western blot evaluation of cytoplasmic and nuclear protein extracts. Furthermore, NRF2 inhibition abolished the protective effects of TSA on HCAECs. These data demonstrate that TSA represses ferroptosis via activation of NRF2 in HCAECs. (c) 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
基金:
TCM
Science and Technology of Guangdong Provincial Hospital of Chinese
Medicine (grant number YN2019MJ16).
第一作者机构:[1]The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, 510220, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
He Lina,Liu Ying-Yi,Wang Kun,et al.Tanshinone IIA protects human coronary artery endothelial cells from ferroptosis by activating the NRF2 pathway[J].BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS.2021,575:1-7.doi:10.1016/j.bbrc.2021.08.067.
APA:
He, Lina,Liu, Ying-Yi,Wang, Kun,Li, Chengxi,Zhang, Weibin...&Xiong, Yujuan.(2021).Tanshinone IIA protects human coronary artery endothelial cells from ferroptosis by activating the NRF2 pathway.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,575,
MLA:
He, Lina,et al."Tanshinone IIA protects human coronary artery endothelial cells from ferroptosis by activating the NRF2 pathway".BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 575.(2021):1-7